您的位置: 首页 > 农业专利 > 详情页

RECOMBINANT AAV VECTORS FOR GENE THERAPY OF HUMAN HEMATOPOIETIC DISORDERS
专利权人:
University of Florida Research Foundation; Incorporated
发明人:
Arun Srivastava,Chen Ling,Mavis Agbandje-McKenna
申请号:
US15552127
公开号:
US20180135074A1
申请日:
2016.02.19
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Provided herein are recombinant AAV (rAAV) particles comprising a nucleic acid vector comprising a parvovirus B 19p6 promoter operatively linked to a heterologous gene, such as a human globin gene, and rAAV capsid proteins comprising one or more amino acid substitutions in a surface exposed loop of the capsid protein that result, e.g., in increased P antigen binding compared to a corresponding un-mutated AAV capsid protein. Also provided are methods and compositions related to such capsid proteins, methods of targeting gene expression to a cell of erythroid lineage, methods of treating a hemoglobinopathy using such rAAV particles, and methods for efficient transduction of a host cell suspension with a rAAV.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充